Team:UCL London

From 2010.igem.org

(Difference between revisions)
Line 1: Line 1:
{{:Team:UCL_London/templates/v2/overall_header}}
{{:Team:UCL_London/templates/v2/overall_header}}
<html>
<html>
 +
 +
javascript:var%20t=((window.getSelection&&window.getSelection())||(document.getSelection&&document.getSelection())||(document.selection&&document.selection.createRange&&document.selection.createRange().text));var%20e=(document.charset||document.characterSet);if(t!=''){location.href='http://translate.google.com/?text='+t+'&hl=en&langpair=auto|ar&tbb=1&ie='+e;}else{location.href='http://translate.google.com/translate?u='+encodeURIComponent(location.href)+'&hl=en&langpair=auto|ar&tbb=1&ie='+e;};
<div id="main">
<div id="main">
<div id="main_bottom">
<div id="main_bottom">

Revision as of 22:24, 28 August 2010

UCL IGEM 2010

RETURN TO IGEM 2010
javascript:var%20t=((window.getSelection&&window.getSelection())||(document.getSelection&&document.getSelection())||(document.selection&&document.selection.createRange&&document.selection.createRange().text));var%20e=(document.charset||document.characterSet);if(t!=''){location.href='http://translate.google.com/?text='+t+'&hl=en&langpair=auto|ar&tbb=1&ie='+e;}else{location.href='http://translate.google.com/translate?u='+encodeURIComponent(location.href)+'&hl=en&langpair=auto|ar&tbb=1&ie='+e;};

PROJECT HYPOXON

Abstract

Synthetic biology is now in a position to overcome many, hitherto, cumbersome and resource consuming manufacturing tasks. Society has now accepted the advent of such entities as recombinant insulin , monoclonal antibodies etc as essential for the future well being of human life. We can now use the bio engineered tools available to us to create systems which make manufacturing health or environmentally associated products simpler and more economical.

Project Description

Team

This is UCL's second year running and once again spearheading the project is the Biochemical Engineering department, collaborating with both the Biochemistry and Molecular Biology Departments. .

iGEM Team

Updates

iGEM Twitter